Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 446 results for "dr reddy s"

The week that was: PVR, Dr Reddy's and HCL Tech among 10 names that buzzed during the week
Economic Times

The week that was: PVR, Dr Reddy's and HCL Tech among 10 names...

In the BSE 500 index, 350 stocks closed in the green while the rest ended the week with cuts. Related Companies NSE BSE HCL Technologies ... PEER COMPANIES PVR Ltd. PEER COMPANIES NEW DELHI: Bluechip indices consolidated for the third week on the trot, ... Economic Times, 16 hours ago
Dr Reddy's shares extend rally; zoom nearly 10% Hindustan Times, 2 days ago
[x]  

145 images for dr reddy s

First Post.com, 3 days ago
Economic Times, 4 days ago
Economic Times, 1 day ago
Economic Times, 1 day ago
Economic Times, 2 days ago
Economic Times, 2 minutes ago
Economic Times, 2 days ago
Times of India, 4 days ago
Economic Times, 2 days ago
Equitymaster.com, 2 days ago
First Post.com

RDIF, Dr Reddy's Lab tie up for Sputnik V human trials, distribution of 100 mn doses of the COVID-19 vaccine in India

RDIF, Dr Reddy's Lab tie up for Sputnik V human trials, distribution of 100 mn doses of the COVID-19 vaccine in India
 First Post.com3 days ago Russia, Dr Reddy’s tie up for Sputnik V trial  Times of India4 days ago Russia confirms deal with Dr. Reddy's for COVID-19 vaccine 'Sputn...  DNA4 days ago Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine  Rediff.com4 days ago
[x]  
Money Control

Hold Dr. Reddy#39;s Lab; target of Rs 5325: Emkay Global Financial

Emkay Global Financial recommended hold rating on Dr. Reddy#39;s Lab with a target price of Rs 5325 in its research report dated September 17, 2020.
 Money Control2 days ago Accumulate Dr. Reddy#39;s Laboratories; target of Rs 4834: Dolat Capital  Money Control2 days ago Trade Spotlight: HCL Technologies, Dr Reddy’s Hindalco in focus  Money Control2 days ago Dr Reddy’s settles patent suit with Celgene  Hindu Business Line3 days ago
[x]  
Economic Times

Natco Pharma soars 17% as path to launch Revlimid generic clears

Natco Pharma would be the first company to launch Revlimid (lenalidomide) in March 2022 as Dr Reddy’s settlement clears the path for the company. Dr Reddy’s would launch sometime after it (we assume 6 months) and would have market share restrictions lower ...
 Economic Times2 days ago Dr Reddy's Laboratories launches over-the-counter eye allergy drop in US  Economic Times3 days ago Dr Reddy's Labs Gains On Launching Eye Allergy Drop In US Market  NDTV3 days ago Dr Reddy#39;s launches OTC eye allergy drop in US  Money Control3 days ago
[x]  
Economic Times

Neutral on Dr. Reddy's Labs, target price Rs 4600: Motilal Oswal

Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 84529.23 Crore) operating in Pharmaceuticals sector.
 Economic Times2 days ago Hold Dr. Reddy's Labs, target price Rs 5325: Emkay Global  Economic Times2 days ago Reduce Dr. Reddy’s Labs; target of Rs 3940: HDFC Securities  Money Control1 month ago Neutral Dr Reddy’s Labs; target of Rs 4600: Motilal Oswal  Money Control1 month ago
Economic Times

Licence to sell cancer drug biggest opportunity for Dr Reddy’s in US market: Nirmal Bang

The good news on the stock probably will sustain and it will continue to outperform the index, says Vishal Manchanda, Equity Research Analyst - Pharma, Nirmal Bang Securities. What are the implications of Dr Reddy’s settling its litigation with Celgene for ...
 Economic Times2 days ago
Money Control

Cadila Healthcare in talks with RDIF to bring COVID-19 vaccine to India; share hit 52-week high

RDIF has agreed to supply 10 crore doses of the world’s first coronavirus vaccine to Dr Reddy’s Laboratories. However, it wanted to scale up the supply of the vaccine and hence started talks with at least four Indian drug makers, including that of Zydus ...
 Money Control2 days ago
Economic Times

Stock market update: Nifty Pharma index up 2%; Dr Reddy's Lab jumps 4%

was trading with gains at 12:16PM (IST) on Tuesday. Shares of Aurobindo Pharma (up 4.85 per cent), Dr Reddys Laboratories (up 3.96 per cent), Cipla (up 3.76 per cent), Lupin (up 3.26 per cent) and Biocon (up 2.56 per cent) were among the top gainers. While ...
 Economic Times5 days ago Stock market update: Pharma stocks down; Dr Reddy's Lab slips 2%  Economic Times1 month ago
Hindu Business Line

Dr Reddy's launches Fulvestrant injection in US

Dr. Reddy’s Laboratories Ltd has launched Fulvestrant Injection per single-dose syringe, a therapeutic equivalent generic version of Faslodex (fulves
 Hindu Business Line1 week ago Dr Reddy's launches Wilson's disease and cystinuria treatment capsules in US  Economic Times3 weeks ago Dr Reddy’s launches Penicillamine Capsules in US  Hindu Business Line3 weeks ago Dr Reddy’s launches Wilson’s disease treatment capsules in US  Hindu Business Line3 weeks ago
Money Control

Stocks in the news | EIH, Dr Reddy#39;s, SBI, Shriram City Union Finance, Motherson Sumi, Bharat Road Network

EIH, Motherson Sumi Systems, Rushil Décor, Forbes Company, Parag Milk Foods, Kirloskar Brothers, Indiabulls Housing Finance, Shree Cement and Bharat Dynamicsare also among the stocks in focus today.
 Money Control1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Happening by Location Click on any location on map to view latest news by location
 
More     Less